Overview/purpose The transition from a postdoctoral fellow to an independent academic clinician-scientist is a major step in the career development of both physician-scientists and scientists interested in biological disorders. The vulnerability of this step, especially in the present climate of reduced funding possibilities, is well recognized by the National Institutes of Health (NIH) and other major scientific funding agencies, such as the American Society of Hematology (ASH), the American Heart Association (AHA), and the Leukemia and Lymphoma Society. Because the NIH grants remain the gold standard of such awards and because these awards tend to be for a substantial sum of support for 4 to 5 years, the NIH awards will be the focus of this presentation. Much of the presentation below applies to granting mechanisms through the National, Heart, Lung and Blood Institute (NHLBI) for physician-scientists, but certainly the general advice also applies to other NIH-funding sources through the National Cancer Institute (NCI) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other national societies. Details of the available programs are best obtained from the website of each organization, or go to www.nih.gov and pick “Grants Funding Opportunities.” The K08, K23 and the new K99/R00 Research Career Award (RCA) grant mechanisms are excellent means for beginning an academic career as a clinician-scientist. The K08 award is intended for individuals whose research is primarily laboratory based, while the K23 award is for investigators whose focus is patient-oriented research. The K99/R00 RCA award is for individuals somewhat further along in their career development who need a limited number of years of further mentoring prior to transitioning to an individual award. All of these grants remain strongly supported by the NIH as a mechanism for assisting junior faculty in achieving independence, but the availability of each award varies greatly between Institutions, and one needs to know both the official and unofficial status of each award in each Institution to know what would be best for an individual candidate. In this session, the details of how to successfully apply for these awards will be discussed primarily from the viewpoints of a recent successful applicant at the NIH and a senior scientist who has been involved in such reviews for the NHLBI. Most important to remember is that, unlike an RO1 application, these awards are mentored grant applications. Therefore, not only is the proposed science evaluated, but more importantly, the following components are evaluated: the candidate, the mentor, the career development plan, the potential of the proposed research to train the applicant for an independent career, and institutional support for the candidate.
Read full abstract